Advertisement
Screener

ANAPTYSBIO, INC. (ANAB) Net Margin

ANAPTYSBIO, INC. (ANAB) Net Margin

  • 2026-03-31: Net Margin -206.93%.
  • 2025-12-31: Net Margin 45.83%.
  • 2025-09-30: Net Margin 19.80%.
  • 2025-06-30: Net Margin -173.52%.

Complete source-backed net margin history.

Available history
2015-12-31 to 2026-03-31
Data captured

Historical Net Margin

DateNet Margin
2026-03-31-206.93%
2025-12-3145.83%
2025-09-3019.80%
2025-06-30-173.52%
2025-03-31-141.62%
2024-12-31-50.53%
2024-09-30-109.44%
2024-06-30-425.30%
2024-03-31-612.01%
2023-12-31-468.75%
2023-09-30-1124.41%
2023-06-30-1151.59%
2023-03-31-3220.89%
2022-12-31-387.97%
2022-09-30-2591.03%
2022-06-30-2677.14%
2022-03-31-3737.63%
2021-12-31-3218.40%
2021-09-30-31.91%
2021-06-30-1.43%
2021-03-31-161.49%
2020-12-3156.08%
2020-03-31-55.08%
2019-12-31-675.43%
2019-06-30-479.24%
2018-09-30-319.16%
2017-12-31-228.70%
2017-06-30-38.34%
2016-12-31-166.23%
2016-09-30-34.69%
2016-06-3039.69%
2016-03-31-18.25%

Annual Net Margin

DateNet Margin
2025-12-31-5.64%
2024-12-31-159.10%
2023-12-31-953.66%
2022-12-31-1251.33%
2021-12-31-91.49%
2020-12-31-26.57%
2019-12-31-1216.70%
2018-12-31-1233.12%
2017-12-31-300.70%
2016-12-31-25.53%
2015-12-31-30.76%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Innoviva, Inc. (INVA)United States$1.493B4.62
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
OMEROS CORP (OMER)United States$1.456B5.50
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74